Inhibitory effect of PMC, a potent hydrophilic α-tocopherol derivative, on vascular smooth muscle cell proliferation

The pivotal role of PKC-α translocation

Chao Chien Chang, Jie Jen Lee, Cheng-Wen Chiang, Thanasekaran Jayakumar, George Hsiao, Cheng Ying Hsieh, Joen Rong Sheu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Content: Vascular smooth muscle cells (VSMCs) play a major role in the pathogenesis of atherosclerosis and restenosis, and thus the excessive proliferation of VSMCs contributes to neointimal thickening during atherosclerosis and restenosis. PMC (2,2,5,7,8-pentamethyl-6-hydroxychromane) is the most potent hydrophilic derivative of the α-tocopherols; it acts as a potent anti-inflammatory and free-radical scavenger. Objective: The present study was designed to examine the inhibitory mechanisms of PMC in VSMC proliferation. Materials and methods: VSMC proliferation and cytotoxicity were measured by MTT and LDH assays, respectively. The cell cycle and translocation of PKC-α in VSMCs were used by flow cytometry and confocal microscope, respectively. To detect PKC-α translocation and activation in VSMCs, immunoblotting was performed in the present study. Results: In this study, we demonstrate an anti-proliferative effect of PMC in VSMCs. Concentration- dependent inhibition of serum-induced VSMC proliferation was observed in PMC (20 and 50μM)-treated cells. PMC pretreatment also arrested VSMC cell cycle progression at the G2/M phase. Furthermore, PMC exhibited obvious inhibitory effects on phorbol 12-myristate 13-acetate (PMA)-induced protein kinase C (PKC)-α translocation and phospho-(Ser/Thr) substrate phosphorylation. Discussion and conclusion: The inhibitory mechanisms of PMC on VSMC proliferation is mediated, at least in part, by inhibition of PKC-α translocation and causes cell cycle arrest in the G2/M phase. PMC treatment may represent a novel approach for lowering the risk of or improving function in abnormal VSMC proliferation-related vascular diseases.

Original languageEnglish
Pages (from-to)938-946
Number of pages9
JournalPharmaceutical Biology
Volume48
Issue number8
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Tocopherols
Vascular Smooth Muscle
Protein Kinase C
Smooth Muscle Myocytes
Cell Proliferation
G2 Phase
Cell Division
Atherosclerosis
Cell Cycle Proteins
Free Radical Scavengers
Cell Cycle Checkpoints
Vascular Diseases
Immunoblotting
Cell Cycle
Flow Cytometry
Acetates
Anti-Inflammatory Agents
Phosphorylation

Keywords

  • α-tocopherol
  • Cell cycle
  • G2/M phase
  • Protein kinase C-α; PMC
  • Vascular smooth muscle cells

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Pharmaceutical Science
  • Complementary and alternative medicine
  • Molecular Medicine

Cite this

Inhibitory effect of PMC, a potent hydrophilic α-tocopherol derivative, on vascular smooth muscle cell proliferation : The pivotal role of PKC-α translocation. / Chang, Chao Chien; Lee, Jie Jen; Chiang, Cheng-Wen; Jayakumar, Thanasekaran; Hsiao, George; Hsieh, Cheng Ying; Sheu, Joen Rong.

In: Pharmaceutical Biology, Vol. 48, No. 8, 08.2010, p. 938-946.

Research output: Contribution to journalArticle

@article{cf85e12b70d1417a8671fb57accb2c1c,
title = "Inhibitory effect of PMC, a potent hydrophilic α-tocopherol derivative, on vascular smooth muscle cell proliferation: The pivotal role of PKC-α translocation",
abstract = "Content: Vascular smooth muscle cells (VSMCs) play a major role in the pathogenesis of atherosclerosis and restenosis, and thus the excessive proliferation of VSMCs contributes to neointimal thickening during atherosclerosis and restenosis. PMC (2,2,5,7,8-pentamethyl-6-hydroxychromane) is the most potent hydrophilic derivative of the α-tocopherols; it acts as a potent anti-inflammatory and free-radical scavenger. Objective: The present study was designed to examine the inhibitory mechanisms of PMC in VSMC proliferation. Materials and methods: VSMC proliferation and cytotoxicity were measured by MTT and LDH assays, respectively. The cell cycle and translocation of PKC-α in VSMCs were used by flow cytometry and confocal microscope, respectively. To detect PKC-α translocation and activation in VSMCs, immunoblotting was performed in the present study. Results: In this study, we demonstrate an anti-proliferative effect of PMC in VSMCs. Concentration- dependent inhibition of serum-induced VSMC proliferation was observed in PMC (20 and 50μM)-treated cells. PMC pretreatment also arrested VSMC cell cycle progression at the G2/M phase. Furthermore, PMC exhibited obvious inhibitory effects on phorbol 12-myristate 13-acetate (PMA)-induced protein kinase C (PKC)-α translocation and phospho-(Ser/Thr) substrate phosphorylation. Discussion and conclusion: The inhibitory mechanisms of PMC on VSMC proliferation is mediated, at least in part, by inhibition of PKC-α translocation and causes cell cycle arrest in the G2/M phase. PMC treatment may represent a novel approach for lowering the risk of or improving function in abnormal VSMC proliferation-related vascular diseases.",
keywords = "α-tocopherol, Cell cycle, G2/M phase, Protein kinase C-α; PMC, Vascular smooth muscle cells",
author = "Chang, {Chao Chien} and Lee, {Jie Jen} and Cheng-Wen Chiang and Thanasekaran Jayakumar and George Hsiao and Hsieh, {Cheng Ying} and Sheu, {Joen Rong}",
year = "2010",
month = "8",
doi = "10.3109/13880200903305526",
language = "English",
volume = "48",
pages = "938--946",
journal = "Pharmaceutical Biology",
issn = "1388-0209",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Inhibitory effect of PMC, a potent hydrophilic α-tocopherol derivative, on vascular smooth muscle cell proliferation

T2 - The pivotal role of PKC-α translocation

AU - Chang, Chao Chien

AU - Lee, Jie Jen

AU - Chiang, Cheng-Wen

AU - Jayakumar, Thanasekaran

AU - Hsiao, George

AU - Hsieh, Cheng Ying

AU - Sheu, Joen Rong

PY - 2010/8

Y1 - 2010/8

N2 - Content: Vascular smooth muscle cells (VSMCs) play a major role in the pathogenesis of atherosclerosis and restenosis, and thus the excessive proliferation of VSMCs contributes to neointimal thickening during atherosclerosis and restenosis. PMC (2,2,5,7,8-pentamethyl-6-hydroxychromane) is the most potent hydrophilic derivative of the α-tocopherols; it acts as a potent anti-inflammatory and free-radical scavenger. Objective: The present study was designed to examine the inhibitory mechanisms of PMC in VSMC proliferation. Materials and methods: VSMC proliferation and cytotoxicity were measured by MTT and LDH assays, respectively. The cell cycle and translocation of PKC-α in VSMCs were used by flow cytometry and confocal microscope, respectively. To detect PKC-α translocation and activation in VSMCs, immunoblotting was performed in the present study. Results: In this study, we demonstrate an anti-proliferative effect of PMC in VSMCs. Concentration- dependent inhibition of serum-induced VSMC proliferation was observed in PMC (20 and 50μM)-treated cells. PMC pretreatment also arrested VSMC cell cycle progression at the G2/M phase. Furthermore, PMC exhibited obvious inhibitory effects on phorbol 12-myristate 13-acetate (PMA)-induced protein kinase C (PKC)-α translocation and phospho-(Ser/Thr) substrate phosphorylation. Discussion and conclusion: The inhibitory mechanisms of PMC on VSMC proliferation is mediated, at least in part, by inhibition of PKC-α translocation and causes cell cycle arrest in the G2/M phase. PMC treatment may represent a novel approach for lowering the risk of or improving function in abnormal VSMC proliferation-related vascular diseases.

AB - Content: Vascular smooth muscle cells (VSMCs) play a major role in the pathogenesis of atherosclerosis and restenosis, and thus the excessive proliferation of VSMCs contributes to neointimal thickening during atherosclerosis and restenosis. PMC (2,2,5,7,8-pentamethyl-6-hydroxychromane) is the most potent hydrophilic derivative of the α-tocopherols; it acts as a potent anti-inflammatory and free-radical scavenger. Objective: The present study was designed to examine the inhibitory mechanisms of PMC in VSMC proliferation. Materials and methods: VSMC proliferation and cytotoxicity were measured by MTT and LDH assays, respectively. The cell cycle and translocation of PKC-α in VSMCs were used by flow cytometry and confocal microscope, respectively. To detect PKC-α translocation and activation in VSMCs, immunoblotting was performed in the present study. Results: In this study, we demonstrate an anti-proliferative effect of PMC in VSMCs. Concentration- dependent inhibition of serum-induced VSMC proliferation was observed in PMC (20 and 50μM)-treated cells. PMC pretreatment also arrested VSMC cell cycle progression at the G2/M phase. Furthermore, PMC exhibited obvious inhibitory effects on phorbol 12-myristate 13-acetate (PMA)-induced protein kinase C (PKC)-α translocation and phospho-(Ser/Thr) substrate phosphorylation. Discussion and conclusion: The inhibitory mechanisms of PMC on VSMC proliferation is mediated, at least in part, by inhibition of PKC-α translocation and causes cell cycle arrest in the G2/M phase. PMC treatment may represent a novel approach for lowering the risk of or improving function in abnormal VSMC proliferation-related vascular diseases.

KW - α-tocopherol

KW - Cell cycle

KW - G2/M phase

KW - Protein kinase C-α; PMC

KW - Vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=77955195120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955195120&partnerID=8YFLogxK

U2 - 10.3109/13880200903305526

DO - 10.3109/13880200903305526

M3 - Article

VL - 48

SP - 938

EP - 946

JO - Pharmaceutical Biology

JF - Pharmaceutical Biology

SN - 1388-0209

IS - 8

ER -